Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

Abstract Hyponatremia is a common electrolyte disorder in cancer patients and has been associated with poor prognosis. A frequent cause of cancer‐related hyponatremia is the syndrome of inappropriate antidiuretic hormone (SIADH). This study was a post hoc subgroup analysis of the SALT‐1 (Study of As...

Full description

Bibliographic Details
Main Authors: Richard J. Gralla, Fatima Ahmad, Jaime D. Blais, Joseph Chiodo III, Wen Zhou, Linda A. Glaser, Frank S. Czerwiec
Format: Article
Language:English
Published: Wiley 2017-04-01
Series:Cancer Medicine
Subjects:
breast cancer
head and neck cancer,
Hyponatremia,
lung cancer,
renal cancer
syndrome of inappropriate antidiuretic hormone (SIADH)
Online Access:https://doi.org/10.1002/cam4.805

Internet

https://doi.org/10.1002/cam4.805

Similar Items